INDUCTION OF PARTIAL IMMUNITY TO INFLUENZA BY A NEURAMINIDASE-SPECIFIC VACCINE

被引：221
|
作者：
COUCH, RB
KASEL, JA
GERIN, JL
SCHULMAN, JL
KILBOURNE, ED
机构：
[1] OAK RIDGE NATL LAB, ROCKVILLE LAB, MOLEC ANAT PROGRAM, ROCKVILLE, MD USA
[2] CITY UNIV NEW YORK, MT SINAI SCH MED, DEPT MICROBIOL, NEW YORK, NY USA
[3] NIAID, LAB CLIN INVEST, BETHESDA, MD USA
[4] BAYLOR UNIV, COLL MED, DEPT MICROBIOL & IMMUNOL, 1200 MOURSUND AVE, HOUSTON, TX 77025 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 1974年 / 129卷 / 04期
关键词：
D O I：
10.1093/infdis/129.4.411
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：411 / 420
页数：10
相关论文
共 50 条
  • [41] SPECIFIC SERUM FOR INFLUENZA-VIRUS NEURAMINIDASE
    ROVNOVA, ZI
    KOSYAKOV, PN
    ISAEVA, EI
    POSEVAYA, TA
    VOPROSY VIRUSOLOGII, 1974, (02) : 189 - 193
  • [42] Induction and isolation of protective influenza neuraminidase specific antibodies in humans following seasonal vaccination.
    Kobie, James
    Piepenbrink, Michael
    Nogales, Aitor
    Martinez-Sobrido, Luis
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [43] Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice
    Wohlbold, Teddy John
    Chromikova, Veronika
    Tan, Gene S.
    Meade, Philip
    Amanat, Fatima
    Comella, Phillip
    Hirsh, Ariana
    Krammer, Florian
    JOURNAL OF VIROLOGY, 2016, 90 (02) : 851 - 861
  • [44] INTERFERON INDUCTION BY INFLUENZA-VIRUS - SIGNIFICANCE OF NEURAMINIDASE
    CHOMIK, M
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1981, 29 (01) : 109 - 114
  • [45] Induction of protective T cell immunity against influenza using a novel peptide vaccine
    Wilkinson, Tom
    Pleguezuelos, Olga
    Robinson, Stuart
    Stoloff, Gregory
    Lambkin-Williams, Rob
    Oxford, John
    Mann, Alex
    Gilbert, Anthony
    Caparros-Wanderley, Wilson
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [46] Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)
    Matsuo, K
    Yoshikawa, T
    Asanuma, H
    Iwasaki, T
    Hagiwara, Y
    Chen, Z
    Kadowaki, S
    Tsujimoto, H
    Kurata, T
    Tamura, S
    VACCINE, 2000, 18 (24) : 2713 - 2722
  • [47] Induction of Influenza-Specific Mucosal Immunity by an Attenuated Recombinant Sendai Virus
    Le, Thuc-vy L.
    Mironova, Elena
    Garcin, Dominique
    Compans, Richard W.
    PLOS ONE, 2011, 6 (04):
  • [48] Formulation development of a stable influenza recombinant neuraminidase vaccine candidate
    Li, Bing
    Ustyugova, Irina V.
    Szymkowicz, Lisa
    Zhu, Shaolong
    Ming, Marin
    Fung, Karen Y. Y.
    Cortes, Guadalupe
    James, D. Andrew
    Hrynyk, Michael
    Rahman, Nausheen
    Brookes, Roger H.
    Ausar, Salvador F.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [49] EGFRvIII vaccine-specific induction of humoral and cell-mediated immunity
    Ramakrishna, Venky
    Beacock-Sharp, Helen
    Ward, George
    He, Li-Zhen
    Dillon, Janette
    Young, Lesley
    Merryweather, Andy
    Champion, Brian
    Keler, Tibor
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 649 - 649
  • [50] Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine
    Kumamoto, T
    Huang, EK
    Paek, HJ
    Morita, A
    Matsue, H
    Valentini, RF
    Takashima, A
    NATURE BIOTECHNOLOGY, 2002, 20 (01) : 64 - 69
12345